Milnacipran Hydrochloride Tablet
Product Images NDC 51991-034

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Milnacipran Hydrochloride (NDC 51991-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Milnacipran 01)

FDA Label Image

Principal Display Panel (Milnacipran 02)

FDA Label Image

Principal Display Panel (Milnacipran 03)

FDA Label Image

Principal Display Panel (12.5 mg Tablet Bottle Label)

Principal Display Panel (12.5 mg Tablet Bottle Label)
Each film-coated tablet contains 125 mg Milnacipran HCl. The usual dosage information can be found in the package insert provided. It is important to keep this and all drugs out of reach of children and dispense in a tightly closed container as stated in the USP. The tablets should be stored at 25°C (77°F) with excursions permitted between 15°C and 30°C (between 59°F and 86°F). Pharmacies can print medication guides at www.breckenridgepharma.com. The tablets are available in a pack of 60 and should be dispensed with the Medication Guide to each patient. Manufactured by Centaur Pharmaceuticals Pvt. Ltd. in India and distributed by Breckenridge Pharmaceutical, Inc. in Berkeley Heights, NJ. Revised in November 2025. NDC 51991-034-06.*
FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
Each film-coated tablet contains 25mg Milnacipran HCI. The usual dosage should be checked in the package insert for full prescribing information. It is important to keep this medication and all drugs out of the reach of children. Dispensing should be done in a tightly closed container as specified in the USP. This medication should be stored at 25°C (77°F) with excursions allowed between 15°C and 30°C (between 59°F and 86°F) as per USP Controlled Room Temperature guidelines. Pharmacists are instructed to dispense the Medication Guide separately to each patient. The medication is manufactured by Centaur Pharmaceuticals Pvt. Ltd. in India and distributed by Breckenridge Pharmaceutical, Inc. in the USA. The revised date of this information is 01/2026. More details can be found at www.breckenridgepharma.com.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
This is a description for Milnacipran HCI tablets. Each film-coated tablet contains 50 mg of Milnacipran HCI. The usual dosage and storage instructions are provided. It is advised to keep this medication out of the reach of children and store it in a tightly closed container at temperatures between 15°C and 30°C. The medication is manufactured by Centaur Pharmaceuticals Pvt. Ltd. in Pune, India, and distributed by Breckenridge Pharmaceutical in Berkeley Heights, NJ. The package insert contains full prescribing information, which should be dispensed to each patient separately.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
This text provides information about a medication called Milnacipran HCI in the form of film-coated tablets, with each tablet containing 100 mg of the active ingredient. The usual dosage is not specified, and it is recommended to refer to the package insert for complete prescribing information. The medication should be kept out of reach of children and dispensed in a tightly closed container according to USP standards. The storage temperature should be maintained at 25°C (77°F) with permitted excursions between 15°C and 30°C (59°F and 86°F). The manufacturer is Centaur Pharmaceuticals Pvt. Ltd from India, and the distributor is Breckenridge Pharmaceutical, Inc. from Berkeley Heights, NJ. Pharmacists are instructed to dispense the medication guide separately to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.